Search

Did you mean
crohn disease
Your search for "Crohn%E2%80%99s%20disease" gave back 51143 results.
Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of...
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog: 
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog: 
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog: 
MRRPB5
January 2024
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
LPI
February 2023
Price: USD 3,660.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
Catalog: 
Global Markets Direct
March 2022
Price: USD 3,500.00
The global Human Microbiome Therapeutics market size was valued at US$ 944.6 million in 2023. With growing demand in downstream market, the Human...
LPI
February 2024
Price: USD 3,660.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog: 
MRRPB5
January 2024
Price: USD 2,900.00
The global Remicade (Infliximab) and Biosimilar market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4% CAGR...
GIR
June 2023
Price: USD 4,480.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog: 
MRRPB5
November 2023
Price: USD 2,900.00
Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of...
LPI
March 2023
Price: USD 3,660.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
GIR
January 2023
Price: USD 3,480.00
Smart pill technology is a revolutionary technological innovation that has reduced the gap between healthcare and digital technology. Smart pills or...
MRRPB5
February 2024
Price: USD 2,900.00
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic...
Catalog: 
MRRPB5
August 2023
Price: USD 4,900.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
LPI
February 2023
Price: USD 3,660.00

Contact Us for Custom Market Research Solutions

 

Custom Market Research Reports

Filter By Industry

Filter By Country

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected